PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study June 27, 2014 Overview Show transcript Overview The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer. DNA and tumor sequencing information of hundreds of men with advanced prostate cancer will be analyzed to help physicians and patients better understand which medication is right for them. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleTherapeutic sequencing improves outcomes for patients with progressive mCRPCVideoMayo Clinic Study Suggests Routine Prostate Size Evaluation Not As Effective in Cancer Screening VID-20439986 Medical Professionals PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study